Lessons from the skeleton: was the Women's Health Initiative (WHI) a primary prevention trial?
Kleerekoper
Michael
M
Endocrine Division, Wayne State University, Detroit, Michigan, USA.
D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D018849:Controlled Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000172:deficiency; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D011372:Progestins / Q000627:therapeutic use*; D012107:Research Design; D012306:Risk; D016387:Women's Health
D004164:Diphosphonates; D004967:Estrogens; D011372:Progestins